These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6685811)

  • 1. [Mezlocillin in serum, renal and prostatic tissue and its clinical efficacy].
    Seppelt U; Bertermann H
    Med Welt; 1983 Nov; 34(46):1309-11. PubMed ID: 6685811
    [No Abstract]   [Full Text] [Related]  

  • 2. Concentrations of mezlocillin in the serum, heart valves, muscle and subcutaneous tissue of patients undergoing open-heart surgery.
    Daschner F; Just HM; Kappstein I; Spillner H; Schlosser V
    Infection; 1985; 13(4):182-3. PubMed ID: 4044045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azlocillin and mezlocillin concentration in human prostatic tissue.
    Smith RP; Wilbur HJ; Bassey C; Baltch AL
    Chemotherapy; 1988; 34(4):267-71. PubMed ID: 3208544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of penetration and clearance of mezlocillin in the bronchopulmonary tract.
    Braga PC; Marchi E; Scaglione F; Scarpazza G; Faravelli M; Fraschini F
    Int J Clin Pharmacol Res; 1984; 4(5):361-5. PubMed ID: 6519850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of Mezlocillin in open-heart surgery].
    Yuda T; Morishita Y; Maruko M; Taira A
    Kyobu Geka; 1985 Sep; 38(9):695-9. PubMed ID: 4079179
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of mezlocillin in patients with hepatobiliary dysfunction.
    Meyers BR; Srulevitch ES; Sacks HS; Hirschman SZ; Worner TM; Wormser GP; Jacobson J
    J Antimicrob Chemother; 1986 Dec; 18(6):709-13. PubMed ID: 3818496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High serum concentrations of mezlocillin in a critically ill patient with renal and hepatic dysfunction.
    Cooper BE; Nester TJ; Armstrong DK; Dasta JF
    Clin Pharm; 1986 Sep; 5(9):764-6. PubMed ID: 3757449
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of saturable clearance during high-dose mezlocillin therapy.
    Drusano GL; Forrest A; Fiore D; Auger F; Caplan ES
    Antimicrob Agents Chemother; 1984 Nov; 26(5):686-8. PubMed ID: 6517555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct evaluation of mezlocillin concentrations in bronchial tissue.
    Pirali F; Ravizzola G; Colombrita D; Flamminio G; Caruso A; Gargiulo F; Peroni L; Manni M; Manca N; Turano A
    J Chemother; 1989 Jul; 1(4 Suppl):509-11. PubMed ID: 16312507
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic profile of cefotetan in different clinical conditions.
    Fraschini F; Scaglione F; Mezzetti M; Meroni M; Cicchetti F; Scarpazza P; Scarpazza G
    Drugs Exp Clin Res; 1988; 14(8):547-53. PubMed ID: 3248508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kinetics of active metabolites of mezlocillin in tube tissue].
    Anger H; Buchholz F; Perquy L; Sonntag HG
    Med Welt; 1983 Aug; 34(31-32):863-5. PubMed ID: 6621336
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of the pharmacokinetics of mezlocillin.
    Bergan T
    J Antimicrob Chemother; 1983 May; 11 Suppl C():1-16. PubMed ID: 6352604
    [No Abstract]   [Full Text] [Related]  

  • 13. [HPLC study of the pharmacokinetics of mezlocillin administered by 30-minute infusion and comparison with the direct intravenous route].
    Jehl F; Peter JD; Monteil H; Dupeyron JP; Minck R
    Pathol Biol (Paris); 1984 May; 32(5):312-7. PubMed ID: 6739140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of mezlocillin in the pleural fluid].
    Kitzis M; Branger C
    Presse Med; 1985 Nov; 14(38):1970. PubMed ID: 2933711
    [No Abstract]   [Full Text] [Related]  

  • 15. Biliary excretion of mezlocillin in patients with hepatic disease.
    Hildebrandt R; Gundert-Remy U; Raedsch R; Sieg A; Stiehl A
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kinetics of mezlocillin in injured subjects].
    Cingolani ML; Ferrante L; Pigini P; Valente M
    Boll Soc Ital Biol Sper; 1986 Apr; 62(4):479-86. PubMed ID: 3741685
    [No Abstract]   [Full Text] [Related]  

  • 17. Penetration of mezlocillin into pancreatic juice.
    Pederzoli P; Orcalli F; Falconi M; Bozzini L; Martini N
    J Antimicrob Chemother; 1986 Mar; 17(3):397. PubMed ID: 3700296
    [No Abstract]   [Full Text] [Related]  

  • 18. Solid-phase ion-pair extraction and liquid chromatography of mezlocillin in serum.
    Jones CW; Chmel H
    Clin Chem; 1988 Oct; 34(10):2155-6. PubMed ID: 3168240
    [No Abstract]   [Full Text] [Related]  

  • 19. Overview of acylureidopenicillin pharmacokinetics.
    Bergan T
    Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic prophylaxis in high-risk biliary tract surgery: a comparison of mezlocillin and cefotetan. Preliminary results.
    De Nunno T; Savio S; Castelli A; Alegente G; De Lalla F
    J Chemother; 1989 Jul; 1(4 Suppl):979-80. PubMed ID: 16312732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.